ECMO: Clinical Trials

19 trials for ECMO, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 recruiting, 4 completed, 3 not yet recruiting, 2 unknown. 7 Not applicable, 2 Phase 1, 2 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable7Recruiting 5, Completed 1, Unknown 1
Phase 12Not yet recruiting 1, Recruiting 1
Phase 22Not yet recruiting 1, Recruiting 1
Phase 41Active not recruiting 1

Follow ECMO: new trials by email Literature Review of ECMO trials Research Report on ECMO

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PACE: Prostacyclin AntiCoagulation in ECMO
Dose-escalation study of epoprostenol as adjunct anticoagulation in ECMO - ECMO
Phase 1 / Phase 2Not yet recruitingGarrett Keim442026-10-012026-09-24
TwichView-guided Atricurium Dose Adjustment Trial
EMG-based quantitative TOF-guided atracurium titration - ARDS, TTM
Not applicableRecruitingFu Jen Catholic University Hospital1202026-08-192026-09-08
PERCEPTION - Super-Early Neuroprognostication in eCPR Patients
Automated Pupillometry, continuous near-infrared spectroscopy (cNIRS) - Resuscitation, Extra Corporeal Life Support
RecruitingMedical University of Vienna452026-05-122026-05-14
Early Intra-aortic Balloon Pump Use After Venoarterial Extracorporeal Membrane Oxygenation
Early IABP use, Conventional approach - ECMO
Not applicableRecruitingBeijing Anzhen Hospital3582026-03-222026-03-24
Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children
End-expiratory lung volume optimization maneuver with PEEP titration, Standard Care (in control arm) - Congenital Heart Disease, Cardiopulmonary Bypass
Phase 1 / Phase 2RecruitingCharite University, Berlin, Germany802025-12-052026-10-15
Effect of Initiation of Veno-venous ECMO on Urine Output and Acute Kidney Injury
ARDS (Acute Respiratory Distress Syndrome), Acute Kidney Injury
CompletedUniversity Hospital, Ghent762025-12-012026-01-30
EVOLUTION OF D-DIMER AS A MARKER OF BLEEDING RISK ON ECMO
Blood sampling collection - ECMO, Mplementation of a Veno-venous VV or Veno-arterial VA
Not yet recruitingUniversity Hospital, Strasbourg, France1002025-11-272025-12-01
A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation
Nafamostat, Heparin - ECMO
Not applicableRecruitingBeijing Chao Yang Hospital1402025-05-102026-09-09
Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention
Standby cannulated ECMO, Prophylactic ECMO - ECMO, High-risk PCI
Not applicableRecruitingBeijing Anzhen Hospital1762025-03-212026-05-13
Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
Red Blood Cell transfusion - Transfusion, Red Blood Cell
Not applicableRecruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)5262024-11-262026-08-14
The ECMOCYP (cytochromes P450 Activity) Study
phenotype - ECMO, Cardiogenic Shock
RecruitingUniversity Hospital, Geneva462024-10-012024-10-28
Virtual Reality Training for ECMO Circuit Checks
Virtual Reality ECMO Simulation Training, Instructional Video of Certified Perfusionists on Performing a Circuit Check - ECMO, Training Effectiveness
Not applicableCompletedLeiden University Medical Center422024-01-292025-08-24
Precise Treatment of Ceftazidime-Avibactam in Patients With CRO Infections Under the Guidance of TDM and PPK Model
ceftazidime avibactam - ECMO, Carbapenem-Resistant Enterobacteriaceae Infection
Not yet recruitingSichuan Provincial People's Hospital502024-01-012024-01-18
Can Blood Panels Provide Early Warning of Bleeding in Patients on ECMO?
Blood test of factor levels - ECMO, Bleeding
WithdrawnMontefiore Medical Center2021-12-012022-04-28
Effects of Ulinastatin on Inflammatory Response During ECMO Support
ulinastatin - ECMO, Inflammatory Response
UnknownNanfang Hospital, Southern Medical University1442021-07-262021-08-04
Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP
Low flow ECMO driving by CVVH machine - COVID-19, ECMO
Not applicableUnknownPeking Union Medical College Hospital102020-02-202020-06-16
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study
subcutaneous heparin anticoagulation - ECMO, Heparin
Phase 4Active not recruitingBaylor Research Institute1002018-10-102026-01-30
To Construct a Prognosis Prediction Model for ECMO Patients Based on Machine Learning Algorithms
ECMO
CompletedZhujiang Hospital2902018-01-012024-10-23
Cardinality Matching Study of Early v.s. Delayed VV ECMO in Severe Respiratory Failure
Acute Respiratory Failure, ECMO
CompletedUniversity of Cambridge6672011-12-012021-04-27

Narrower conditions

Acute Kidney Injury (1)  ·  Acute Lung Injury (1)  ·  Anemia (1)  ·  COVID-19 (1)  ·  Heart Defects, Congenital (1)  ·  Hemorrhage (1)  ·  Respiratory Distress Syndrome (1)  ·  Respiratory Insufficiency (1)  ·  Shock, Cardiogenic (1)  ·  Tetralogy of Fallot (1)

Broader conditions

Respiratory Tract Diseases (4)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Lung Diseases (3)  ·  Cardiovascular Abnormalities (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiration Disorders (2)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Heart Defects, Congenital (1)

Interventions

Erythrocyte Transfusion (1)  ·  Extracorporeal Membrane Oxygenation (1)  ·  Heparin (1)  ·  Phenotype (1)  ·  Standard of Care (1)  ·  avibactam, ceftazidime drug combination (1)  ·  nafamostat (1)  ·  urinastatin (1)

Sponsors

Beijing Anzhen Hospital (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Baylor Research Institute (1)  ·  Beijing Chao Yang Hospital (1)  ·  Charite University, Berlin, Germany (1)  ·  Fu Jen Catholic University Hospital (1)  ·  Garrett Keim (1)  ·  Leiden University Medical Center (1)  ·  Medical University of Vienna (1)  ·  Montefiore Medical Center (1)  ·  Nanfang Hospital, Southern Medical University (1)  ·  Peking Union Medical College Hospital (1)  ·  Sichuan Provincial People's Hospital (1)  ·  University Hospital, Geneva (1)  ·  University Hospital, Ghent (1)

Countries

China (6)  ·  Austria (2)  ·  Belgium (2)  ·  Netherlands (2)  ·  United States (2)  ·  France (1)  ·  Germany (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  Taiwan (1)

Top investigators

Alexander P.J. Vlaar, PhD (1)  ·  Bing Sun, MD (1)  ·  Gary Schwartz, MD (1)  ·  Kiri Mackersey, MBChB (1)  ·  Xiaotong Hou, MD (1)  ·  Xiaotong Hou, MD, PhD (1)  ·  Yun Long (1)  ·  Zhongqing Chen, doctor (1)

Results publications

PMID 32454016, PMID 34307397, PMID 37548758

NIH funding

2023 (2), 2019 (1)